Blueshift Asset Management, LLC
Position in BMRN — Biomarin Pharmaceutical Inc
CIK 1727827
RED BANK, NJ
Position in BMRN
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$465,942
-$127,294 QoQ
Shares Held
8,143
-24.5% QoQ
Ownership
0.004%
of shares outstanding
% of Portfolio
0.13%
of 13F equity value
Holder Rank
#347
of 561 holders
Holding Since
Mar 2021
6 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMRN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026Blueshift Asset Management, LLC holds $9,217,770 across 26 Biotechnology names. BMRN ranks #7 (5.1% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | REGN |
Regeneron Pharmaceuticals, Inc.
|
1,843 | $1,149,184 | |
| 2 | ROIV |
Roivant Sciences Ltd.
|
30,383 | $1,075,254 | |
| 3 | AXSM |
Axsome Therapeutics, Inc.
|
2,834 | $693,678 | |
| 4 | ALNY |
Alnylam Pharmaceuticals, Inc.
|
2,118 | $637,581 | |
| 5 | APGE |
Apogee Therapeutics, Inc.
|
4,209 | $558,660 | |
| 6 | INSM |
INSMED Inc
|
4,800 | $511,776 | |
| 7 | BMRN |
Biomarin Pharmaceutical Inc
This page
|
8,143 | $465,942 | |
| 8 | ARWR |
Arrowhead Pharmaceuticals, Inc.
|
4,819 | $392,796 |
All Filings in BMRN
Export CSV
6 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $465,942 | 8,143 | Shares | Sole | 2026-08-14 | |
| 2025-06-30 | $593,236 | 10,792 | Shares | Sole | 2025-08-13 | |
| 2024-12-31 | $349,289 | 5,314 | Shares | Sole | 2025-02-11 | |
| 2022-09-30 | $213,874 | 2,523 | Shares | Sole | 2022-11-14 | |
| 2022-03-31 | $635,535 | 8,243 | Shares | Sole | 2022-05-12 | |
| 2021-03-31 | $789,457 | 10,455 | Shares | Sole | 2021-05-06 | |
| No filing history on record for this holder in this stock. | ||||||